Aquablation Therapy

DEVICE3 trials

Sponsors

University of Bonn, PROCEPT BioRobotics

Conditions

BPH With Urinary Obstruction With Other Lower Urinary Tract SymptomsLocalized Prostate Cancer

Unknown Phase

WATER III: Aquablation vs. Transurethral Laser Enucleation of Large Prostates (80 - 180mL) in Benign Prostatic Hyperplasia

Active, not recruitingNCT04801381

University of BonnBPH With Urinary Obstruction With Other Lower Urinary Tract Symptoms

Start: 2020-12-16End: 2029-10-31Updated: 2025-02-06

WATER IV Prostate Cancer

Active, not recruitingNCT06651632

PROCEPT BioRoboticsLocalized Prostate Cancer

Start: 2025-02-03End: 2037-01-01Target: 280Updated: 2026-05-04

WATER IV PCa (AS Sub-study)

Not yet recruitingNCT07650448

PROCEPT BioRoboticsLocalized Prostate Cancer

Start: 2026-09-01End: 2038-12-01Target: 333Updated: 2026-08-04

Related Papers

WATER versus WATER II 5‐year update: Comparing <scp>Aquablation</scp> therapy for benign prostatic hyperplasia in 30–80‐cm<sup>3</sup> and 80–150‐cm<sup>3</sup> prostates

BJUI Compass2024-09-098 citations

Aquablation Therapy in Large Prostates (80-150 mL) for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: Final WATER II 5-Year Clinical Trial Results.

2023-04-2827 citations